Tendersinfo Gulf

Filter Search

Europe

Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Nilotinib. 2026-05-10
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Cetrorelix - Medicines 2026-05-10
Germany Abschluss Nicht-exklusiver Rabattvereinbarungen Nach § 130 A Abs. 8 Sgb V Mit Dem Wirkstoff Meloxicam 2026-05-10
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Para. 8 Sgb V With The Active Ingredient Fesoterodine 2026-05-10
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V In The Period From 01.01.2025 30.06.2026 - Drug 2026-05-10
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Buserelin 2026-05-10
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Para. 8 Sgb V With The Active Ingredient Dihydrocodeine 2026-05-10
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Para. 8 Sgb V With The Active Ingredient Fesoterodine 2026-05-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Mometasone In The Dosage Form Cre And The Pack Size 90 G. 2026-05-10
Germany Abschluss Nicht-exklusiver Rabattvereinbarungen Nach § 130 A Abs. 8 Sgb V Mit Dem Wirkstoff Acemetacin 2026-05-10
Whats app